New Delhi, Aug. 28 -- The last few years have not been easy for India's pharmaceuticals industry, with consolidation of buyers in the US and accompanying pricing pressure. In an interview, Nilesh Gupta, managing director of Lupin Ltd, said the company is bullish on the Indian market, which is growing very well. Edited excerpts:...